Zhan He Wu

University of Sydney

Dr. Zhan He Wu graduated from Harbin Medical University, China, and received his Master’s degree in 1985 from the same university. He received his Ph.D. degree in 1993 from the University of New South Wales, Australia. Since 1996, he has been working in the field of human genetic disease studies in the Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children’s Hospital Westmead, Affiliated to the University of Sydney, mainly on hematological malignancies such as leukemia and lymphoma, and inherited bone marrow failure syndromes, including Fanconi anemia (it is named as the prone cancer syndrome and paradigm for cancer and aging research). Dr. Zhan He Wu has published more than 60 original articles, more than 60 scientific conference presentations, and five chapters in books. He was granted as a Founding Fellow of Royal College of Pathologist for Australasia in 2011. In the past, he has organized many national scientific conferences. He was invited as the Chair for the Euro-Global Conference on Pediatrics and Neonatology 2018, 13–15, SEP, ROME, and delivered the welcome message as well. He has been involved in medical journal reviewing and editing and invited by nine international journals as a reviewer, associate editor, guest editor, editor, column chair, and so on. Currently, he is editing two professional books in English for a UK publisher: Germline Mutations Associated Leukemia and Rare Diseases.

2books edited

4chapters authored

Latest work with IntechOpen by Zhan He Wu

Rare diseases are a group of genetic disorders occurring in a small percentage of the population with the conditions being chronic but incurable. Approximately 7000 to 8000 different types have been identified and about 350 million people globally are affected in childhood and adulthood, resulting in enormous physical, mental, and psychological suffering and financial burden. It is imperative for medical scientists, clinicians, communities, and societies to ensure appropriate care is applied to ease the suffering of such patients. The extraordinary and unprecedented hallmark in the field of rare diseases has revolutionized modern human medicine with exciting and advancing developments of the genomic era over the last two decades. Patients with rare diseases have been receiving increasing benefits in care and life quality improvements than ever before. This book intends to share and exchange the advancing knowledge and experiences from the authors, who have the necessary expertise within the various topics and subjects in the research, diagnosis, and management of rare diseases. It is hoped they are able to provide further benefits to patients and families with the development of early and accurate diagnosis and effective therapies.

Go to the book